On May 24, 2012 researcbers, engineers, and clinicians gathered to discuss the clinical, translational, and basic science aspects of lung cancer and explore opportunities for interdisciplinary collaboration.
Yolonda Colson, Dana-Farber Cancer Institute
Tyler Jacks, Koch Institute
Matt Meyerson, Dana-Farber Cancer Institute (not recorded)
Alice Shaw, MGH and Koch Institute